drugset / Trial / NCT02961634
Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
Phase 3
Unknown
46 enrolled
MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA
Buranello e Rodrigues Consultoria em Desenvolvimento Farmacêutico Ltda ME · collab
RandomizedParallel-groupSingle-blindSupportive care
Summary
Single-center study, single blind, comparative with the objective of evaluating the efficacy and safety of an investigational product as an adjunct in the treatment of onychomycosis improvement of 90 days ± 2 days.
Timeline
- Start
- 2017-04
- Primary completion
- 2017-08
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciclopirox | Unknown | 8 % | Topical |